Page last updated: 2024-11-04

terfenadine and Carcinoid Tumor

terfenadine has been researched along with Carcinoid Tumor in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Modlin, IM1
Lawton, GP1
Tang, LH1
Geibel, J1
Abraham, R1
Darr, U1

Other Studies

1 other study available for terfenadine and Carcinoid Tumor

ArticleYear
The mastomys gastric carcinoid: aspects of enterochromaffin-like cell function.
    Digestion, 1994, Volume: 55 Suppl 3

    Topics: Animals; Calcium; Carcinoid Tumor; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured;

1994